Neurodegenerative central nervous system Langerhans cell histiocytosis and coincident hydrocephalus treated with vincristine/cytosine arabinoside. Pediatric Blood & Cancer, vol.54, pp.416-423, 2010. ,
, Diagnostic and Statistical. Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR â ), American Psychiatric Association, 2000.
Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X?, British Journal of Haematology, vol.169, pp.3-13, 2015. ,
,
Endocrine involvement in pediatric-onset Langerhans' cell histiocytosis: a populationbased study, The Journal of Pediatrics, vol.144, pp.344-350, 2004. ,
Langerhans cell histiocytosis: fascinating dynamics of the dendritic cell-macrophage lineage, Immunological Reviews, vol.234, pp.213-232, 2010. ,
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages, Blood, vol.127, pp.2672-2681, 2016. ,
Course and clinical impact of magnetic resonance imaging findings in diabetes insipidus associated with Langerhans cell histiocytosis, Pediatric Blood & Cancer, vol.43, pp.59-65, 2004. ,
Neuropathology of CNS disease in Langerhans cell histiocytosis, Brain: A Journal of Neurology, vol.128, pp.829-838, 2005. ,
DALHX-and LCH I and II Study Committee. (2006) Risk factors for diabetes insipidus in langerhans cell histiocytosis, Pediatric Blood & Cancer, vol.46, pp.228-233 ,
Central nervous system disease in Langerhans cell histiocytosis, Histiocyte Society CNS LCH Study Group, vol.156, p.1, 2010. ,
Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, Pediatric Blood & Cancer, vol.51, pp.71-75, 2000. ,
URL : https://hal.archives-ouvertes.fr/inserm-00255977
Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation, Blood, vol.121, pp.1495-1500, 2013. ,
, , 2004.
, Histiocyte Society-Late Effects Study Group, Pediatric Blood & Cancer, vol.42, pp.438-444
Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years, Pediatric Blood & Cancer, vol.60, pp.175-184, 2013. ,
Vemurafenib use in an infant for high-risk langerhans cell histiocytosis, JAMA Oncology, vol.1, pp.836-838, 2015. ,
BRAF mutation correlates with high-risk langerhans cell histiocytosis and, Journal of Clinical Oncology, vol.34, pp.3023-3030, 2016. ,
Circulating cell-free BRAF(V600E) as a biomarker in children with Langerhans cell histiocytosis, British Journal of Haematology, vol.178, pp.457-467, 2017. ,
Retinoic acid therapy in 'degenerativelike' neuro-langerhans cell histiocytosis: a prospective pilot study, Pediatric Blood & Cancer, vol.43, pp.55-58, 2004. ,
Neurodegenerative central nervous system disease as late sequelae of Langerhans cell histiocytosis, Report from the Japan LCH Study Group. Haematologica, vol.93, pp.615-618, 2008. ,
Japan LCH Study Group (JLSG). (2015) Follow-up of pediatric patients treated by IVIG for Langerhans cell histiocytosis (LCH)-related neurodegenerative CNS disease, International Journal of Hematology, vol.101, pp.191-197 ,
Incidence and pattern of radiological central nervous system Langerhans cell histiocytosis in children: a population based study. Pediatric Blood & Cancer, vol.56, pp.250-257, 2011. ,
The cognitive spectrum in neurodegenerative Langerhans cell histiocytosis, Journal of Neurology, vol.261, pp.1537-1543, 2014. ,
French Langerhans Cell Histiocytosis Study Group. (2006) MRI features of neurodegenerative Langerhans cell histiocytosis. European Radiology, vol.16, pp.2074-2082 ,
A somatic mutation in erythro-myeloid progenitors causes neurodegenerative disease, Nature, vol.549, pp.389-393, 2017. ,
Central nervous system-related permanent consequences in patients with Langerhans cell histiocytosis, Pediatric Blood & Cancer, vol.48, pp.50-56, 2007. ,
Cognitive outcome of long-term survivors of multisystem langerhans cell histiocytosis: a single-institution, cross-sectional study, Journal of Clinical Oncology, vol.21, pp.2961-2967, 2003. ,
Long-term MR imaging course of neurodegenerative Langerhans cell histiocytosis, American Journal of Neuroradiology, vol.28, pp.1022-1028, 2007. ,
18F-FDG PET in neurodegenerative Langerhans cell histiocytosis : results and potential interest for an early diagnosis of the disease, Journal of Neurology, vol.255, pp.575-580, 2008. ,
Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30-year nationwide cohort of 1478 patients under 18 years of age, British Journal of Haematology, vol.174, pp.887-898, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01331987
, A multicentre retrospective survey of Langerhans' cell histiocytosis: 348 cases observed between 1983 and 1993. The French Langerhans' Cell Histiocytosis Study Group, Archives of Disease in Childhood, vol.75, pp.17-24, 1996.
Wechsler Preschool and Primary Scale of Intelligence -Revised. The Psychological Corporation, 1989. ,
Wechsler Intelligence Scale for Childrenâ-Fourth Edition (WISCâ-IV). Pearson, 2003. ,
Wechsler Adult Intelligence Scale-Fourth Edition (WAIS-IV), 2008. ,
Pattern and course of neurodegeneration in Langerhans cell histiocytosis, The Journal of Pediatrics, vol.153, pp.127-132, 2008. ,